IS Implementation, Adoption and Diffusion in Healthcare
暂无分享,去创建一个
[1] S. Ramsey,et al. Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs. , 2004, The American journal of managed care.
[2] A. Roses,et al. Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications , 2003, Journal of Molecular Medicine.
[3] G. Poste. Molecular diagnostics: a powerful new component of the healthcare value chain , 2001, Expert review of molecular diagnostics.
[4] R. Kisabeth,et al. Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care. , 2001, Mayo Clinic proceedings.
[5] Leach Dh. A new world view of genetics service models. , 2000, Online journal of issues in nursing.
[6] D. Simonson,et al. Valuing Quality of Life and Improvements in Glycemic Control in People With Type 2 Diabetes , 1998, Diabetes Care.
[7] W. Manning,et al. The Cost to Health Plans of Poor Glycemic Control , 1997, Diabetes Care.
[8] R. Califf. Defining the balance of risk and benefit in the era of genomics and proteomics. , 2004, Health affairs.
[9] F. Rodríguez de Castro,et al. Optimizing Treatment Outcomes in Severe Community-Acquired Pneumonia , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.